{
  "ticker": "ANRO",
  "company_name": "Alto Neuroscience, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05419869",
      "title": "Pilot Decentralized Trial",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Major Depressive Disorder",
      "start_date": "2022-06-01",
      "completion_date": "2023-01-26",
      "enrollment": 0,
      "sponsor": "Alto Neuroscience"
    },
    {
      "nct_id": "NCT05157945",
      "title": "ALTO-300 in Depression (ALTO-300-004)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Major Depressive Disorder",
      "start_date": "2022-02-03",
      "completion_date": "2023-05-05",
      "enrollment": 0,
      "sponsor": "Alto Neuroscience"
    },
    {
      "nct_id": "NCT05922878",
      "title": "Study of ALTO-300 in MDD",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Major Depressive Disorder",
      "start_date": "2023-06-08",
      "completion_date": "2026-12",
      "enrollment": 0,
      "sponsor": "Alto Neuroscience"
    },
    {
      "nct_id": "NCT06502964",
      "title": "Study of ALTO-101 in Patients With Schizophrenia",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Schizophrenia, Cognitive Impairment",
      "start_date": "2024-06-11",
      "completion_date": "2026-03",
      "enrollment": 0,
      "sponsor": "Alto Neuroscience"
    },
    {
      "nct_id": "NCT06656416",
      "title": "ALTO-100 in Bipolar Disorder With Depression (BD-D)",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Bipolar Disorder I or II With a Major Depressive Episode",
      "start_date": "2024-10-02",
      "completion_date": "2026-10",
      "enrollment": 0,
      "sponsor": "Alto Neuroscience"
    },
    {
      "nct_id": "NCT04388189",
      "title": "Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion",
      "status": "WITHDRAWN",
      "phase": "PHASE4",
      "condition": "Major Depressive Disorder",
      "start_date": "2020-10-15",
      "completion_date": "2023-05-30",
      "enrollment": 0,
      "sponsor": "Alto Neuroscience"
    },
    {
      "nct_id": "NCT05118750",
      "title": "ALTO-300 in Depression",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Major Depressive Disorder",
      "start_date": "2021-12-13",
      "completion_date": "2023-05-09",
      "enrollment": 0,
      "sponsor": "Alto Neuroscience"
    },
    {
      "nct_id": "NCT05117632",
      "title": "ALTO-100 in MDD and/or PTSD",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Major Depressive Disorder, Post Traumatic Stress Disorder",
      "start_date": "2021-12-20",
      "completion_date": "2022-12-09",
      "enrollment": 0,
      "sponsor": "Alto Neuroscience"
    },
    {
      "nct_id": "NCT06391593",
      "title": "PD, PK, and Safety of ALTO-203 in Patients With MDD",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Major Depressive Disorder, Anhedonia",
      "start_date": "2024-03-25",
      "completion_date": "2025-04-21",
      "enrollment": 0,
      "sponsor": "Alto Neuroscience"
    },
    {
      "nct_id": "NCT04388202",
      "title": "Leveraging EEG for Antidepressant Prediction With Sertraline and Escitalopram",
      "status": "WITHDRAWN",
      "phase": "PHASE4",
      "condition": "Major Depressive Disorder",
      "start_date": "2020-10-15",
      "completion_date": "2023-05-30",
      "enrollment": 0,
      "sponsor": "Alto Neuroscience"
    }
  ],
  "summary": {
    "total_trials": 11,
    "by_phase": {
      "PHASE2": 9,
      "PHASE4": 2
    },
    "by_status": {
      "COMPLETED": 6,
      "RECRUITING": 3,
      "WITHDRAWN": 2
    },
    "active_trials": 3,
    "completed_trials": 6,
    "conditions": [
      "Bipolar Disorder I or II With a Major Depressive Episode",
      "Major Depressive Disorder",
      "Major Depressive Disorder, Anhedonia",
      "Major Depressive Disorder, Post Traumatic Stress Disorder",
      "Schizophrenia, Cognitive Impairment"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:16:26.551356",
    "search_query": "Alto Neuroscience, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Alto+Neuroscience,+Inc."
  }
}